Skip to main content
Log in

Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

We evaluated the recent incidence of surgery and the changing surgery trends for ulcerative colitis (UC) in Japan due to the increasing use of anti-tumor necrosis factor (TNF) agents.

Methods

A questionnaire survey was performed to assess the number of surgeries, surgical indications, surgical timing, and immunosuppressive treatments before surgery between 2007 and 2017.

Results

A total of 3801 surgical cases were reported over 11 years. The prevalence of UC surgery decreased over the period studied. The rate of prednisolone (PSL) use did not change. The prevalence of both calcineurin inhibitors (CNIs) and anti-TNF agents increased during the period studied (p < 0.01). The prevalence of urgent/emergent surgery did not change. The most distinctive change in surgical indications was the increase in cancer/dysplasia (CAC), the prevalence of which increased from 20.2% in 2007 to 34.8%.

Conclusion

The prevalence of UC surgery seems to be decreasing according to the increasing rate of anti-TNF agent and CNI administration. However, the indication of CAC significantly increased. Further research should evaluate whether or not long-term remission maintained with several agents can lead to increasing CAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–544.

    PubMed  Google Scholar 

  2. Eriksson C, Cao Y, Rundquist S, Zhulina Y, Henriksson I, Montgomery S, et al. Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963–2010. Aliment Pharmacol Ther. 2017;46:748–57.

    Article  CAS  PubMed  Google Scholar 

  3. Reich KM, Chang HJ, Rezaie A, Wang H, Goodman KJ, Kaplan GG, et al. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther. 2014;40:629–38.

    Article  CAS  PubMed  Google Scholar 

  4. Moore SE, McGrail KM, Peterson S, Raval MJ, Karimuddin AA, Phang PT, et al. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada. Dis Colon Rectum. 2014;57:83–90.

    Article  PubMed  Google Scholar 

  5. Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137:1250–60.

    Article  CAS  PubMed  Google Scholar 

  6. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990;31:329–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chow DK, Leong RW, Tsoi KK, Ng SS, Leung WK, Wu JC, et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009;104:647–54.

    Article  PubMed  Google Scholar 

  8. Moskovitz DN, Van Assche G, Maenhout B, Arts J, Ferrante M, Vermeire S, et al. Incidence of colectomy during long-term follow up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:760–5.

    Article  CAS  PubMed  Google Scholar 

  9. Campbell S, Travis SPL, Jewell DP. Cyclosporine use in acute severe ulcerative colitis: a long term experience. Eur J Gastroenterol Hepatol. 2005;17:79–84.

    Article  CAS  PubMed  Google Scholar 

  10. Komaki Y, Komaki F, Ido A, Sakuraba A. Efficacy and safety of tacrolimus therapy for active ulcerative colitis; a systematic review and meta-analysis. J Crohns Colitis. 2016;10:484–94.

    Article  PubMed  Google Scholar 

  11. Higashi A, Watanabe Y, Ozasa K, Hayashi K, Aoike A, Kawai K. Prevalence and mortality of ulcerative colitis and Crohn's disease in Japan. Gastroenterol Jpn. 1988;23:521–6.

    Article  CAS  PubMed  Google Scholar 

  12. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol. 2009;44:659–65.

    Article  PubMed  Google Scholar 

  13. Seto Y, Kakeji Y, Miyata H, Iwanaka T. National Clinical Database (NCD) in Japan for gastroenterological surgery: brief introduction. Ann Gastroenterol Surg. 2017;1:80–1.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kakeji Y, Takahashi A, Udagawa H, Unno M, Endo I, Kunisaki C, et al. Surgical outcomes in gastroenterological surgery in Japan: Report of National Clinical database 2011–2016. Ann Gastroenterol Surg. 2018;2:37–54.

    Article  PubMed  Google Scholar 

  15. https://www.nanbyou.or.jp/entry/62. Accessed 24 Jan

  16. Kimura H, Takahashi K, Futami K, Ikeuchi H, Tatsumi K, Watanabe K, et al. Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? results of a questionnaire survey of surgical institutions in Japan. Surg Today. 2016;46:930–8.

    Article  CAS  PubMed  Google Scholar 

  17. Kaplan GG, Seow CH, Ghosh S, Molodecky N, Rezaie A, Moran GW, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol. 2012;107:1879–87.

    Article  CAS  PubMed  Google Scholar 

  18. Narula N, Fine M, Colombel JF, Marshall JK, Reinisch W. Systematic review: sequential rescue therapy in severe ulcerative colitis—do the benefits outweigh the risks? Inflamm Bowel Dis. 2015;21:1683–94.

    Article  PubMed  Google Scholar 

  19. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–33

    Article  CAS  PubMed  Google Scholar 

  21. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444–511.

    Article  CAS  PubMed  Google Scholar 

  22. Yamadera M, Ueno H, Kobayashi H, Konishi T, Ishida F, Yamaguchi T, et al. Current status and clinical studies of familial adenomatous polyposis in Japan. Surg Today. 2017;47:690–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Motoi Uchino.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in association with this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uchino, M., Ikeuchi, H., Hata, K. et al. Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study. Surg Today 49, 1066–1073 (2019). https://doi.org/10.1007/s00595-019-01845-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-019-01845-2

Keywords

Navigation